NCR Online Journal

The Global Veterinary Vaccines Market to Amount to $12119.03 Million by 2028

 Breaking News
  • No posts were found

The Global Veterinary Vaccines Market to Amount to $12119.03 Million by 2028

May 19
21:30 2022
The Global Veterinary Vaccines Market to Amount to $12119.03 Million by 2028
veterinary-vaccines-market
As per Triton’s report, the global veterinary vaccines market, which generated $7086.10 million in 2021, is likely to chart a 7.46% of CAGR by the year 2028.

A recent study by Triton Market Research titled ‘Global Veterinary Vaccines Market,’ covers the Global Analysis and Forecasts by Disease Type (Porcine Disease, Bovine Disease, Aquaculture Disease, Poultry Disease, Canine Disease, Other Disease Types), by Product Type (Subunit Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines, Attenuated Vaccines, Inactivated Vaccines, Conjugate Vaccines), by Animal Type (Companion Animals [Feline, Canine, Equine], Aquaculture, Livestock Animals [Cattle, Pigs, Poultry, Sheep, Other Livestock Animals]), and by Regional Outlook (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa).

 

Request Free Sample of the Global Veterinary Vaccines Market Report @ https://www.tritonmarketresearch.com/reports/veterinary-vaccines-market#request-free-sample

 

  A report by Triton Market Research predicts the global veterinary vaccines market to grow with a CAGR of 7.46% in the forecast years 2022-2028. It is likely to accumulate revenue worth $12119.03 million by 2028.

The consumption of meat and other animal-derived products is on the rise. To fulfill this demand, animal farmers are also looking for ways to grow and maintain a sufficient animal population. Animal diseases are generally viral in nature and spread quickly from one to the other. 

This increases the chances of disease incidence and spread, and has thereby increased the demand for veterinary vaccines as well. Veterinary vaccines help avoid the mass spreading of diseases and reduce their intensity. This is largely driving the studied market’s growth. 

However, companies require authorization and approval from regulatory bodies to market and sell these vaccines. This is a major hurdle for them as there is no single universally acceptable approval procedure, with every country/region having its own standard parameters. Thus, such technicalities and legalities are hampering the overall market performance.

The market for veterinary vaccines is segmented into disease type, product type, and animal type. Based on disease type, it is divided into porcine disease, bovine disease, aquaculture disease, poultry disease, canine disease, and other disease types. 

Whereas, based on product type, it is segmented into subunit vaccines, DNA vaccines, recombinant vaccines, toxoid vaccines, attenuated vaccines, inactivated vaccines, and conjugate vaccines.

Lastly, on the basis of animal type, the market is categorized into companion animals, aquaculture, and livestock animals. According to companion animals, it consists of feline, canine, and equine. And lastly, according to livestock animals, it consists of cattle, pigs, poultry, sheep, and other livestock animals.

The market in the Asia-Pacific is expected to show the fastest growth globally, over the forecasted period. The region has a high population of livestock, such as pigs, poultry, fish, and cattle, which naturally make it a lucrative market with numerous growth opportunities for market players. On the other hand, the market in North America holds the largest share worldwide and is expected to continue its lead in the coming years. The increase in public awareness and the growing acceptance for using vaccines for improved animal health are responsible for the market growth in this region.

Virbac SA, Ceva Sante Animale, Elanco Animal Health Inc, Phibro Animal Health, Vaxxinova GmbH, Indian Immunologicals Limited, Merck Animal Health, Hester Biosciences Ltd, Hipra, Zoetis Inc, Boehringer Ingelheim International GmbH, and Brilliant Bio Pharma are the well-known players in the veterinary vaccines market.

 

Purchase this Report @  https://www.tritonmarketresearch.com/reports/veterinary-vaccines-market#purchase-option

 

Question & Answer: Veterinary Vaccines Market

Question 1: What is driving the veterinary vaccines market’s growth?

Answer: The consumption of meat and other animal-derived products is on the rise. To fulfill this demand, animal farmers are also looking for ways to grow and maintain a sufficient animal population. Animal diseases are generally viral in nature and spread quickly from one to the other. 

This increases the chances of disease incidence and spread, and has thereby increased the demand for veterinary vaccines as well. Veterinary vaccines help avoid the mass spreading of diseases and reduce their intensity. This is largely driving the studied market’s growth.

Question 2: What factors are hampering the veterinary vaccines market’s performance?

Answer: Companies require authorization and approval from regulatory bodies to market and sell these vaccines. This is a major hurdle for them as there is no single universally acceptable approval procedure, with every country/region having its own standard parameters. Thus, such technicalities and legalities are hampering the overall market performance.

Question 3: Which regions are influencing the growth of the global veterinary vaccines market?

Answer: The market in the Asia-Pacific is expected to show the fastest growth globally, over the forecasted period. The region has a high population of livestock, such as pigs, poultry, fish, and cattle, which naturally make it a lucrative market with numerous growth opportunities for market players. On the other hand, the market in North America holds the largest share worldwide and is expected to continue its lead in the coming years. The increase in public awareness and the growing acceptance for using vaccines for improved animal health are responsible for the market growth in this region.  

Question 4: Who are the well-known players in the veterinary vaccines market?

Answer: Virbac SA, Ceva Sante Animale, Elanco Animal Health Inc, Phibro Animal Health, Vaxxinova GmbH, Indian Immunologicals Limited, Merck Animal Health, Hester Biosciences Ltd, Hipra, Zoetis Inc, Boehringer Ingelheim International GmbH, and Brilliant Bio Pharma are the well-known players in the veterinary vaccines market.

 

Related Report:

Global Veterinary Medicines Market

The global veterinary medicines market is deemed to grow at a CAGR of 4.11% over the estimated duration of 2019-2028. It is expected to garner $32.89 billion worth of revenue by 2028.

A surge in the number of people adopting animals as pets and a rise in the livestock population globally are the factors contributing to the growth of the market. Further, the increase in the prevalence of several medical conditions in animals is the key reason attributable for the growth of the veterinary medicines market.

On the flip side, the stringent regulations pertaining to the use of medicated feed additives are restricting the development of the veterinary medicine market. However, growth in people’s awareness about animal health provides a lucrative opportunity for the market’s growth.

 

About Us:

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

 

Contact Us:

Triton Market Research

196, wards wharf approach

London E16 2EQ

Phone:  +44 7441 911839

Email:  [email protected]

Website: https://www.tritonmarketresearch.com/

Media Contact
Company Name: Triton Market Research
Contact Person: Matt Dixson
Email: Send Email
Phone: +44 7441 911839
Address:196, wards wharf approach London E16 2EQ
Country: United Kingdom
Website: https://www.tritonmarketresearch.com/

Related Articles